Monoclonal Antibodies Specific for SARS-CoV-2 Spike Protein Suitable for Multiple Applications for Current Variants of ConcernMahali S. Morgan, Jody Hobson‐Peters, Thuy T. Le et al.|Viruses|2022Cited by 21